Poland· PL-100065723
Targocid
A teicoplanin product containing teicoplaninum, registered in Poland by Sanofi Winthrop Industrie. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Teicoplanin is registered in 15 of 19 countries.
Countries holding a registration under ATC J01XA02 (teicoplanin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Teicoplanin · ATC J01XA02
15 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Teicoplaninum
- Manufacturer
- Sanofi Winthrop Industrie
- Country
- Poland (PL)
- ATC code
- J01XA02
- ATC class
- Teicoplanin
- Defined daily dose
- 0.4 g, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990336210
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Teicoplanin in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainTARGOCID 400 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE Y PARA PERFUSIONSanofi Aventis S.A.
- SwedenTargocid 400 mg Pulver till injektions-/infusionsvätska, lösningOrifarm AB
- SwitzerlandTeicoplanin-Evultis 400 mg, Polvere e solvente per soluzione iniettabile / per infusione / soluzione oraleEvultis SA
- FinlandTeicoplanin Demo S.A.Demo S.A.
- BelgiumTeicoplanin Bradex 400 mgBradex
- NorwayTargocidSanofi
- United KingdomTargocid 200mg powder and solvent for solution for injection vialsSanofi
- CzechiaTARGOCIDSanofi s.r.o., Praha
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Teicoplanin Accord, Teicoplanin Altan
- Belgium · Targocid, Teicoplanin Bradex
- Bulgaria · Планитек, Планицид
- Cyprus · Talinac, Teicoplanin Aptapharma
- Czechia · Targocid, Teicoplanin Aptapharma
- Germany · Teicoplanin Altan, Teicoplanin Centurion
- Denmark · Targocid, Teicoplanin Demo S.A.
- Spain · Targocid, Teicoplanina Accord
- Finland · Targocid, Teicoplanin Demo S.A.
- France · Targocid, Teicoplanine Altan
- United Kingdom (Northern Ireland) · Targocid, Teicoplanin
- Greece · Talinac, Targocid
- Croatia · Targocid, Teikoplanin Aptapharma
- Hungary · Targocid, Teicoplanin Anfarm
- Ireland · Targocid, Teicoplanin Hikma
- Italy · Planicid, Targosid
- Luxembourg · Targocid
- Malta · Targocid, Teicoplanin Anfarm
- Netherlands · Targocid, Teicoplanin Sun
- Norway · Teicoplanin Demo S.A.
- Portugal · Teicoplanina Accord, Teicoplanina Altan
- Romania · Targocid, Teicoplanină Aptapharma
- Sweden · Targocid, Teicoplanin Bradex
- Slovenia · Targocid, Teikoplanin Aptapharma
- Slovakia · Targocid, Teicoplanin Aptapharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a0d08b80-12fc-46ac-a4c6-b28beb12936c GET /v1/drugs/a0d08b80-12fc-46ac-a4c6-b28beb12936c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań / do infuzji lub roztworu doustnego",
"source": "urpl",
"strength": "400 mg",
"packaging": "05909990336210 ¦ Lz ¦ 9888\n1 fiol. proszku + 1 amp. rozp.",
"substance": "Teicoplaninum 400 mg",
"common_name": "Teicoplaninum",
"pl_product_id": "100065723",
"pozwolenie_nr": "03362",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about teicoplanin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.